Van TilCorneliusChristian Apologetics, (Presbyterian and Reformed Publishing Co., Phillipsburg, PA, 1976), pg 34, 43, 99-105, 179-180, 195, 197.
4.
WaceH., PiercyW.C.A Dictionary of Early Christian Biography: and Literature to the End of the Sixth Century A.D., With an Account of the Principal Sects and Heresies, (Hendrickson Publishers, Inc., USA, 1999), pg 362
5.
GravesDanDoctors Who Followed Christ, (Kregel Publications, Grand Rapids, MI, 1999), pg 28.
6.
GravesDanDoctors Who Followed Christ, (Kregel Publications, Grand Rapids, MI, 1999), pg 75.
7.
GravesDanDoctors Who Followed Christ, (Kregel Publications, Grand Rapids, MI, 1999), pg 110.
8.
GravesDanDoctors Who Followed Christ, (Kregel Publications, Grand Rapids, MI, 1999), pg 112.
9.
GravesDanDoctors Who Followed Christ, (Kregel Publications, Grand Rapids, MI, 1999), pg 124.
10.
GravesDanDoctors Who Followed Christ, (Kregel Publications, Grand Rapids, MI, 1999), pg 137.
11.
LileyA.W.“Intrauterine Transfusion of Foetus in Haemolytic Disease,”BMJ1963, 2: 110.
12.
Centers for Disease Control and Prevention, “Use of Folic Acid for Prevention of Spina Bifida and Other Neural Tube Defects, 1983-1991,”MMWR1991; 40: 513–516.
13.
NicolaidesK.H., ChengH.H, SniajderR.J.M., MonizC.F.“Fetal Urine Biochemistry in the Assessment of Obstructive Uropathy,”Ant J Obstet Gynecol1992; 166: 932–37.
14.
JohnsonM.P., CorsiP., BarfieldW., HumeR.F., SmithC., FlakeA.W., QuereshiF, EvansM.I.“Sequential Urinalysis Improves Evaluation of Fetal Renal Function in Obstructive Uropathy,”Am J Obstet Gynecol1995; 173: 59–65.
15.
KumarS., FiskN.“Distal Urinary Obstruction,”Clin Perinatol2003, 30: 507–519, and K.H. Nicolaides, H.H Cheng, R.J.M. Sniajder, C.F. Moniz, “Fetal Urine Biochemistry in the Assessment of Obstructive Uropathy,” Am J Obstet Gynecol 1992;166: 932-37.
Van den VeyverI.M., MoiseK.J.Jr.“Fetal RHD Typing by Polymerase Chain Reaction in Pregnancies Complicated by Rhesus Alloimmunization,”Obstet Gynecol1996; 88: 1061–1067.
19.
FinningK.M., MartinR.G., SoothillP.W., AventN.D.“Prediction of Fetal D Status From Maternal Plasma: Introduction of a New Noninvasive Fetal RhD Genotyping Service,”Transfusion2002; 42: 1079–85.
20.
KlumperF.J., van KampI.L., VandenbusscheF.P., MeermanR.H., OepkesD., ScherjonS.A., EilersP.H., KanhaiH.H.“Benefits and Risks of Fetal Red-Cell Transfusion After 32 Weeks Gestation”Eur J Obstet Gynaecol Repro Biol.2000; 92: 91–96.
21.
ZimmermanR., CarpenterR.J.Jr., DurigP., MariG.“Longitudinal Measurement of the Peak Systolic Velocity in the Fetal Middle Cerebral Artery for Monitoring Pregnancies Complicated by Red Cell Alloimmunization – A Prospective Multi-Center Trial With Intention to Treat,”Br J Obstet Gynaecol2001; 109: 746–752.
22.
MariG. for the Collaborative Group for Doppler Assessment of the Blood Velocity of Anemic Fetuses, “Noninvasive Diagnosis by Doppler Ultrasonography of Fetal Anemia Due to Maternal Red-Cell Alloimmunization,”N Engl J Med2000; 342(1): 9–14.
23.
DunnD., WallonM., PeyronF., PetersenE., PeckhamC., GilbertR.“Mother-to-Child Transmission of Toxoplasmosis: Risk Estimates for Clinical Counseling,”Lancet1999; 353: 1829–33.
24.
RomandS., WallonM., FranckJ., ThulliezP., PeyronF., DumonH.“Prenatal Diagnosis Using Polymerase Chain Reaction on Amniotic Fluid for Congenital Toxoplasmosis,”Obstet Gynecol2001; 97(2): 296–300.
25.
GilbertR.E., GrasL., WallonM., PeyronF., AdesA.E., DunnD.T.“Effect of Prenatal Treatment on Mother to Child Transmission of Toxoplasmosis Gondii: Retrospective Cohort Study of 554 Mother-Child Pairs in Lyon, France,”International J of Epidemiol2001; 30(6): 1303–8.
26.
MarkensonG.R., YanceyM.K.“Parvovirus B19 Infections in Pregnancy,”Semin Perinatol1998; 22: 309–317.
PrydeP.G., NugentC.E., PridjianF.“Spontaneous Resolution of Nonimmune Hydrops Fetalis Secondary to Human Parvovirus B19 Infection,”Obstet Gynecol1992; 79: 859–861.
29.
RodisJ.F., BorgidaA.F., WilsonM., EganJ.F., LeoM.V., OdiboA.O., CampbellW.A.“Management of Parvovirus Infection in Pregnancy and Outcomes of Hydrops: A Survey of Members of the Society of Perinatal Obstetricians,”Am J Obstet Gynecol1998; 179: 985–88.
30.
GearyM.P., ChittyL.S., MorrisonJ.J., WrightV., PierroA., RodeckC.H.“Perinatal Outcome and Prognostic Factors in Prenatally Diagnosed Congenital Diaphragmatic Hernia,”Ultrasound Obstet Gynecol1998; 12: 107–111.
31.
CannonC., DildyG.A., WardR., VarnerM.W., DudleyD.J.“A Population-Based Study of Congenital Diaphragmatic Hernia in Utah: 19884994,”Obstet Gynecol1996; 87: 959–63.
32.
AlbaneseC.T., LopooJ., GoldsteinR.B., FillyR.A., FeldsteinV.A., CalenP.W., JenningsR.W., FarrellJ.A., HarrisonM.R.“Fetal Liver Position and Perinatal Outcome For Congenital Diaphragmatic Hernia,”Prenat Diagn1998; 18: 1138–42.
33.
KatzA.L., WiswellT.E., BaumgartS.“Contemporary Controversies in the Management of Congenital Diaphragmatic Hernia,”Clin Perinatal1998; 25: 219–48.
34.
HarrisonM.R., MychaliskaG.B., AlbaneseC.T., JenningsR.W., FarrellJ.A., HawgoodS., SandbergP., LevineA.H., LoboE., FillyR.A.“Correction of Congenital Diaphragmatic Hernia In Utero: IX. Fetuses With Poor Prognosis (Liver Herniation and Low Lung-to-Head Ratio) Can be Saved by Fetoscopic Temporary Tracheal Occlusion”J Pediatr Surg1998; 33: 1017–22; discussion 1022-3.
35.
DeprestJ., GratacosE., NicolaidesK.H.“Fetoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia: Evolution of a Technique and Preliminary Results. FETO Task Group,”Ultrasound Obstet Gynecol2004; 24: 121–126.
36.
StackerJ.T., MadewellJ.E., DrakeR.M.“Congenital Cystic Adenomatoid Malformation of the Lung. Classification and Morphologic Spectrum,”Hum Pathol1977; 8: 155–171.
BulfieldG., SillerW.G., WightP.A., MooreK.J.“X Chromosome-Linked Muscular Dystrophy (MDX) in the Mouse,”Proceedings of the National Academy of Sciences of the United States of America.1984; 81: 1189–1192.
42.
GussoniE., BlauH.M., KunkelM.“The Fate of Individual Myoblasts After Transplantation Into Muscles of DMD Patients,”Nature Medicine1997; 3: 970–977.
43.
HayashiS., PeranteauW.H., ShaabanA.G., FlakeA.W.“Complete Allogenic Hematopoietic Chimerism Achieved by a Combined Strategy of In Utero Hematopoietic Stem Cell Transplantation and Postnatal Donor Lymphocyte Infusion,”Blood2002; 100: 804–812.
44.
Centers for Disease Control and Prevention, “Recommendations for the Use of Folic Acid to Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects,”MMWR1992; 41: 1–8.
45.
EvansM.I., LlurbaE., LandsbergerE.J., O'BrienJ.E., HarrisonH.H.“Impact of Folic Acid Fortification in the United States: Markedly Diminished High Maternal Serum Alpha-Fetoprotein Values,”Obstet Gynecol2004; 103: 474–479.
46.
Centers for Disease Control and Prevention, “Use of Folic Acid for Prevention of Spina Bifida and Other Neural Tube Defects. 1983-1991,”MMWR1991; 40: 513–516.
HolzgreveW., MahonyB.S., GlickP.L.“Sonographic Demonstration of Fetal Sacrococcygeal Teratoma,”Prenat Diagn1985; 5: 245–257 & C. Lockwood, A. Ghidini, R. Romero, J.C. Hobbins, “Fetal Bowel Perforation Simulating Sacrococcygeal Teratoma,” J Ultrasound Med 1988;7: 227-229.
52.
LamY.H., TangM.H., ShekT.W.“Thermocoagulation of Fetal Sacrococcygeal Teratoma,”Prenatal Diagnosis2002; 22(2): 99–101.
53.
HecherK., PlathH., BregenzerT., HansmannM., HackeloerB.J.“Endoscopic Laser Surgery Versus Serial Amniocentesis in the Treatment of Severe Twin-Twin Transfusion Syndrome,”Am J Obstet Gynecol1999; 180(3, Pt 1): 717–24.
54.
CallenP.W.“Ultrasonography” in Obstetrics & Gynecology, 4th edition, 2000, pg 776.
55.
De LiaJ.E., WorthingtonD.“Long-Term Neurodevelopmental Outcome After Intrauterine Laser Treatment for Twin-Twin Transfusion Syndrome (TTTS),”Am J Obstet Gynecol2003; 188(4): 876–880.
56.
Maternal-Fetal Medicine: Principles and Practice, 5th Edition, Editors: Robert K. Creasy and Robert Resnik. Saunders, Philadelphia, PA, 2004, after CS Klenmein with experience with 1384 fetuses over 20 years (114/1384) pg 465.
57.
Maternal-Fetal Medicine: Principles and Practice, 5th Edition, Editors: CreasyRobert K., and ResnikRobert, Saunders, Philadelphia, PA, 2004, pgs 476–477.
58.
SchmidtK.G., UlmerH.E., SilvermanH.N., KleinmanC.S., CopelJ.A.“Perinatal Outcome of Fetal Complete Atrioventricular Block: A Multicenter Experience,”J Am Coll Cardial1991; 17(6): 1360–1366.
59.
TworetzkyW., Wilkins-HangL., JenningsR.W., van der VeldeM.E., MarshallA.C., MarxG.R., ColanS.D., BensonC.B., LockJ.E., PerryS.B.
60.
Circulation2004; 110(15): 2125–2131.
61.
SchechtmanK.B., GrayD.L., BatyJ.D., RothmanS.M.“Decision-Making for Termination of Pregnancies with Fetal Anomalies: Analysis of 53,000 Pregnancies,”Obstet Gynecol2002; 99: 216–222.